Dendritic cells drawn from a sample of the patient's blood are ....

Atricle on Brain Cancer, Dendritic Cell Therapy ...

http://www.mycentraljersey.com/article/20081021/HEALTH/810210311/-1/newsfront

Dendritic cells drawn from a sample of the patient's blood are exposed in a lab dish to the biomarkers of the patient's own tumor, then activated and "educated." These cells then are injected back into the patient and mobilize the immune system to recognize and attack the cancer.

The early results are stunning: It appears as if the vaccine increases survival by as much as 50 percent, according to the Brain Tumor Center of New Jersey. That's music to Montag's ears.
"I could feel the difference, physically," said Montag, who after Labor Day received approval from her surgeon, Dr. Brian Beyerl, to return to work for 15 hours per week. "I just felt better, stronger. I am doing desk work and reviewing charts, but it is exciting to be back."
Charlene Ruggiero, one of Montag's colleagues at Overlook, admires Montag's courage and says Montag provides an example for any brain cancer patients to follow.

"Her optimism, strength and caring nature, in addition to being a nurse in the same shoes as her patients, means the world to them," Ruggiero said. "She offers them something no one else can: tangible hope."